Silo Pharma, Inc.
SILO
$0.6283
-$0.0108-1.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.90M | -4.62M | -4.39M | -3.78M | -3.51M |
| Total Depreciation and Amortization | 11.80K | 9.30K | 6.20K | 3.10K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.60K | -1.60K | 1.10K | 68.10K | 96.70K |
| Change in Net Operating Assets | -319.60K | -21.00K | 551.70K | -114.20K | -133.70K |
| Cash from Operations | -5.19M | -4.64M | -3.83M | -3.83M | -3.55M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.18M | 1.75M | 973.80K | 5.44M | 6.74M |
| Cash from Investing | 1.18M | 1.75M | 973.80K | 5.44M | 6.74M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.84M | 3.41M | 3.41M | 3.41M | 1.67M |
| Repurchase of Common Stock | 0.00 | -57.70K | -173.20K | -367.60K | -513.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.84M | 3.36M | 3.24M | 3.05M | 1.16M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -172.60K | 468.60K | 381.50K | 4.66M | 4.35M |